CCAM
LLY icon

Cascades Capital Asset Management’s Eli Lilly LLY Stock Holding History

Cascades Capital Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44M Sell
2,652
-147
-5% -$149K 1.02% 19
2025
Q4 		$3.01M Sell
2,799
-105
-4% -$100K 1.26% 15
2025
Q3 		$2.22M Buy
2,904
+59
+2% +$43.9K 0.98% 21
2025
Q2 		$2.22M Buy
2,845
+309
+12% +$240K 1.14% 20
2025
Q1 		$2.09M Sell
2,536
-82
-3% -$68.2K 1.13% 21
2024
Q4 		$2.02M Sell
2,618
-43
-2% -$35.6K 1.08% 21
2024
Q3 		$2.36M Buy
+2,661
New +$2.39M 1.3% 15

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cascades Capital Asset Management's LLY Position: Q1 2026 in Review

Cascades Capital Asset Management reduced its Eli Lilly (LLY) stake by 5.3% in Q1 2026, selling an estimated $149K and leaving 2,652 shares worth $2.44M. The position accounts for 1.02% of the portfolio, ranked #19.

Cascades Capital Asset Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.01M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cascades Capital Asset Management held 2,652 shares of Eli Lilly worth $2.44M as of Q1 2026.
  • Cascades Capital Asset Management sold 147 Eli Lilly shares in Q1 2026, an estimated $149K.
  • Eli Lilly made up 1.02% of Cascades Capital Asset Management's portfolio in Q1 2026, its #19 holding.
  • Cascades Capital Asset Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Cascades Capital Asset Management's Eli Lilly position peaked at $3.01M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cascades Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.